Replies to post #76441 on NanoViricides Inc. (NNVC)

[Puffer]

yes, my point is that since the FDA approved orphan designation there was little doubt EMA would approve the designation as well. Stock prices are a game of expectations.... you need to exceed them to get an increase in share price. In this case they were merely met.

[Echo20]

daboze

The Eu countries might also wait until FLUCIDE passes Clinical Trial One.

If so, then there will be a big jump in the PPS of NNVC.

After all, that is SUPER DUPER FLUCIDE now.

It is hard to believe that FLUCIDE is passing each of its targets successfully. If this keeps up there will be MERS and H7N9 testing and TOX success.

With no setbacks this will be as simple as one , two, three.

That will be super impressive and so gain the attention of many more investors and companies.

Echo20